No Data
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings
10 Health Care Stocks With Whale Alerts In Today's Session
A Post-Mortem on Cassava Sciences
Unpacking the Latest Options Trading Trends in Cassava Sciences
SAVA Stock Plunges 84% on Alzheimer's Drug Failure in Late-Stage Study
What's Left in Cassava After Phase 3 Setback for Alzheimer's Drug